Cencora Inc. (NYSE: COR) announced that Chief Financial Officer James F. Cleary will retire effective June 30, 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates.

Cleary, 62, has served as Cencora's CFO since November 2018. He joined the company in February 2015 following its acquisition of MWI Veterinary Supply, where he had served as Chief Executive Officer for over a decade.

"On behalf of the Board and Enterprise Leadership Team, I want to thank Jim for his years of pragmatic leadership, strategic insight and consistent financial stewardship," said Robert P. Mauch, President and Chief Executive Officer of Cencora.

Cleary will assist in the search process for his replacement and serve in an advisory capacity through the end of 2026 to facilitate the transition, according to the company statement.

"Working with this team has been the highlight of my career," Cleary said. "I'm very proud of what we accomplished together at Cencora, enhancing value for all stakeholders."

The company reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026.

Cencora operates as a pharmaceutical distribution and solutions company with more than 51,000 employees worldwide and annual revenue exceeding $300 billion.